Arkolith/Insider Trading/FWBI/Form 4

Romano Sarah

Chief Financial OfficerFirst Wave BioPharma, Inc. (FWBI) · full profile →Form 4 · filed Apr 3, 2024
Net Selling
Open-Market Buys
$0
Open-Market Sells
$317
Net Open-Market Flow
-$317
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Apr 1, 2024Sell(S)75$4.23$31719K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-24-043154) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML